Mukta Madanmohan Agarwal
About Mukta Madanmohan Agarwal
Data last updated:
Mukta Madanmohan Agarwal is a Director at Inlife Pharma Private Limited (since 2018). The company operates in Pharma. Inlife Pharma Private Limited reported revenue of ₹15.84 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Inlife Pharma Private Limited U24100TG1999PTC032540 | Director | 10 Dec 2018 | 1999 | ₹15.84 Cr (FY 2025) | Active |
Board colleagues of Mukta Madanmohan Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kanodia | 00272894 | Inlife Pharma Private Limited | Managing Director |
| Chetan Agarwal | 03619065 | Inlife Pharma Private Limited | Director |
| Prateek Agarwal | 03619060 | Inlife Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukta Madanmohan Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukta Madanmohan Agarwal
Mukta Madanmohan Agarwal currently holds 1 directorship: Inlife Pharma Private Limited (Director, since 10 Dec 2018, revenue ₹15.84 Cr (FY 2025)).
Mukta Madanmohan Agarwal was first appointed on 10 Dec 2018 as Director at Inlife Pharma Private Limited.
The current boards of Mukta Madanmohan Agarwal's companies include Anil Kanodia (Inlife Pharma Private Limited), Chetan Agarwal (Inlife Pharma Private Limited), Prateek Agarwal (Inlife Pharma Private Limited).